{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:20:01Z","timestamp":1759011601856},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"DOI":"10.1097\/qai.0b013e31825c1217","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T07:41:07Z","timestamp":1336722067000},"page":"9-18","source":"Crossref","is-referenced-by-count":4,"title":["Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection"],"prefix":"10.1097","volume":"61","author":[{"given":"Michael A.","family":"Eller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh Anne","family":"Eller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ratto-Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson J.","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Guwatudde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Nails","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Wabwire-Mangen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Marovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan K.","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design.","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1056\/NEJMra0706737","article-title":". The challenge of HIV-1 subtype diversity.","volume":"358","author":"Taylor","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00002030-200312050-00002","article-title":"Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.","volume":"17","author":"Peeters","year":"2003","journal-title":"AIDS"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1089\/088922202320886325","article-title":". Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate.","volume":"18","author":"Harris","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.qai.0000243053.80945.f0","article-title":". Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.","volume":"43","author":"Arroyo","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/512682","article-title":". HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.","volume":"195","author":"Baeten","year":"2007","journal-title":"J Infect Dis"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/314557","article-title":". Human immunodeficiency virus type 1 subtypes differ in disease progression.","volume":"179","author":"Kanki","year":"1999","journal-title":"J Infect Dis"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/527416","article-title":". Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.","volume":"197","author":"Kiwanuka","year":"2008","journal-title":"J Infect Dis"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/340130","article-title":". Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.","volume":"185","author":"Kaleebu","year":"2002","journal-title":"J Infect Dis"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/aid.2010.0054","article-title":". Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.","volume":"26","author":"Conroy","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":". Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":". Virus-specific CD8 cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199710303371803","article-title":". Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.","volume":"337","author":"Musey","year":"1997","journal-title":"N Engl J Med"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":". The first T cell response to transmittedfounder virus contributes to the control of acute viremia in HIV-1 infection.","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":". Dramatic rise in plasma viremia after CD8() T cell depletion in simian immunodeficiency virus-infected macaques.","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/JVI.72.1.164-169.1998","article-title":". Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simianhuman immunodeficiency virus during primary infections of rhesus macaques.","volume":"72","author":"Matano","year":"1998","journal-title":"J Virol"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":". Control of viremia in simian immunodeficiency virus infection by CD8 lymphocytes.","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":". HIV nonprogressors preferentially maintain highly functional HIV-specific CD8 T cells.","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":". CD8 T-cell responses to different HIV proteins have discordant associations with viral load.","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1128\/JVI.01847-06","article-title":". CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.","volume":"81","author":"Geldmacher","year":"2007","journal-title":"J Virol"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":". Vigorous HIV-1-specific CD4 T cell responses associated with control of viremia.","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/386285","article-title":". Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.","volume":"189","author":"Ratto-Kim","year":"2004","journal-title":"J Infect Dis"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","article-title":". Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.","volume":"103","author":"Harari","year":"2004","journal-title":"Blood"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e328337b144","article-title":". Cytotoxic granule release dominates gag-specific CD4 T-cell response in different phases of HIV infection.","volume":"24","author":"Nemes","year":"2010","journal-title":"AIDS"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.146.7.2088","article-title":". Human CD8 T lymphocytes can be divided into CD45RA and CD45RO cells with different requirements for activation and differentiation.","volume":"146","author":"de Jong","year":"1991","journal-title":"J Immunol"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4 and CD8 effector and memory T cell generation.","volume":"4","author":"Seder","year":"2003","journal-title":"Nat Immunol"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":". Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nri1866","article-title":"The descent of memory T-cell subsets.","volume":"6","author":"Lefrancois","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35065118","article-title":". Skewed maturation of memory HIV-specific CD8 T lymphocytes.","volume":"410","author":"Champagne","year":"2001","journal-title":"Nature"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"e4145","DOI":"10.1371\/journal.pone.0004145","article-title":". Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda.","volume":"4","author":"Guwatudde","year":"2009","journal-title":"PLoS ONE"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/CVI.00492-09","article-title":". Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting.","volume":"17","author":"Olemukan","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1128\/JCM.00894-07","article-title":". Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence Ugandan blood bank population.","volume":"45","author":"Eller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jim.2006.04.005","article-title":"Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells.","volume":"313","author":"Jabbari","year":"2006","journal-title":"J Immunol Methods"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"e13983","DOI":"10.1371\/journal.pone.0013983","article-title":". Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.","volume":"5","author":"Currier","year":"2010","journal-title":"PLoS ONE"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets.","volume":"79","author":"Roederer","year":"2011","journal-title":"Cytometry A"},{"key":"R36-2-20210131","first-page":"19","article-title":". The haematological profile of urban black Africans aged 15-64 years in the Cape Peninsula.","volume":"72","author":"Badenhorst","year":"1995","journal-title":"East Afr Med J"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"e3919","DOI":"10.1371\/journal.pone.0003919","article-title":". Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials.","volume":"3","author":"Eller","year":"2008","journal-title":"PLoS ONE"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(72)92409-9","article-title":"Non-genetic neutropenia in Africans.","volume":"2","author":"Ezeilo","year":"1972","journal-title":"Lancet"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(71)90335-7","article-title":"Genetic neutropenia in people of African origin.","volume":"2","author":"Shaper","year":"1971","journal-title":"Lancet"},{"key":"R40-2-20210131","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/088922299310485","article-title":". Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.","volume":"15","author":"Pontesilli","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R41-2-20210131","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/JVI.01830-06","article-title":". Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4 T cells are a consequence of antigen load.","volume":"81","author":"Tilton","year":"2007","journal-title":"J Virol"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1084\/jem.20052246","article-title":". Acquisition of direct antiviral effector functions by CMV-specific CD4 T lymphocytes with cellular maturation.","volume":"203","author":"Casazza","year":"2006","journal-title":"J Exp Med"},{"key":"R43-2-20210131","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":". Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"R44-2-20210131","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1128\/JVI.75.20.9771-9779.2001","article-title":". Multiple effector functions mediated by human immunodeficiency virus-specific CD4() T-cell clones.","volume":"75","author":"Norris","year":"2001","journal-title":"J Virol"},{"key":"R45-2-20210131","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1073\/pnas.0813106106","article-title":". Gag- and Nef-specific CD4 T cells recognize and inhibit SIV replication in infected macrophages early after infection.","volume":"106","author":"Sacha","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R46-2-20210131","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1084\/jem.20100090","article-title":". Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection.","volume":"207","author":"Geldmacher","year":"2010","journal-title":"J Exp Med"},{"key":"R47-2-20210131","doi-asserted-by":"crossref","first-page":"e1000780","DOI":"10.1371\/journal.ppat.1000780","article-title":". HIV controller CD4 T cells respond to minimal amounts of Gag antigen due to high TCR avidity.","volume":"6","author":"Vingert","year":"2010","journal-title":"PLoS Pathog"},{"key":"R48-2-20210131","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1128\/JVI.00980-10","article-title":". HIV controllers with HLA-DRB113 and HLA-DQB106 alleles have strong, polyfunctional mucosal CD4 T-cell responses.","volume":"84","author":"Ferre","year":"2010","journal-title":"J Virol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201209010-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T17:29:51Z","timestamp":1687454991000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201209010-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31825c1217","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,1]]}}}